Lastly, immunohistochemistry analyses supported our transcriptomic findings by showing that L1CAM expression, one of the genes associated with oxaliplatin resistance, was upregulated at both the RNA level in PDOs and protein levels in matched tumor tissues (Figure S4). Here, L1CAM is linked to neoplasm.